CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,018 | 40,138 | ||
| 2024-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,348 | 196,706 | ||
| 2024-05-09 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +100 | $1.08 | $108 | 67,097 |
| 2024-05-09 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −100 | $15.00 | $2K | 66,997 |
| 2024-05-09 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −100 | 203,054 | ||
| 2024-04-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,349 | $1.08 | $7K | 66,997 |
| 2024-04-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,349 | 203,154 | ||
| 2024-04-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 60,648 |
| 2024-04-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 45,156 | ||
| 2024-03-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,348 | $1.08 | $7K | 55,631 |
| 2024-03-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,348 | 209,503 | ||
| 2024-03-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 49,283 |
| 2024-03-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 50,173 | ||
| 2024-02-13 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2024-02-13 | Levy Adam Scott CFO and Secretary | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2024-02-13 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +425,000 | 425,000 | ||
| 2024-02-12 | AKKARAJU SRINIVAS Director | Grant or award | +555,555 | $13.50 | $7.5M | 5,074,916 |
| 2024-02-12 | Samsara BioCapital GP, LLC 10% owner | Purchase | +555,555 | $13.50 | $7.5M | 5,074,916 |
| 2024-02-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +1,672,508 | $13.50 | $22.6M | 2,983,755 |
| 2024-02-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Pre-Funded Warrants (Right to Buy) | +549,755 | $13.50 | $7.4M | 549,755 |
Page 19 of 23 · 446 trades